2,4-Disubstituted pyrimidines were synthesized as a novel class of KDR kinase inhibitors. Evaluation of the SAR of the screening lead compound 1 (KDR IC(50)=105 nM, Cell IC(50)=8% inhibition at 500 nM) led to the potent 3,5-dimethylaniline derivative 2d (KDR IC(50)=6 nM, cell IC(50)=19 nM).
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/s0960-894x(03)00244-0 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!